Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
SRCL

Stericycle Inc

SRCL

47.49USD-1.60 (-3.26%)Delayed as of 08 Dec 2023, 11:11 am
Watchlist

Market Summary

USD47.49-1.60
Delayedas of 08 Dec 2023, 11:11 am
-3.26%

SRCL Stock Price

View Fullscreen

SRCL RSI Chart

SRCL Valuation

Market Cap

4.5B

Price/Earnings (Trailing)

207.34

Price/Sales (Trailing)

1.7

EV/EBITDA

28.72

Price/Free Cashflow

20.45

SRCL Price/Sales (Trailing)

SRCL Profitability

EBT Margin

1.74%

Return on Equity

0.88%

Return on Assets

0.42%

Free Cashflow Yield

4.89%

SRCL Fundamentals

SRCL Revenue

Revenue (TTM)

2.7B

Revenue Y/Y

-5.33%

Revenue Q/Q

-2.39%

SRCL Earnings

Earnings (TTM)

21.9M

Earnings Y/Y

-571.43%

Earnings Q/Q

-538.05%

Price Action

52 Week Range

40.3756.12
(Low)(High)

Last 7 days

4.5%

Last 30 days

19.7%

Last 90 days

10.6%

Trailing 12 Months

-3.6%

How does SRCL drawdown profile look like?

SRCL Financial Health

Current Ratio

0.85

Debt/Equity

0.52

Debt/Cashflow

0.29

SRCL Investor Care

Shares Dilution (1Y)

0.33%

Diluted EPS (TTM)

-0.05

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20232.7B2.7B2.7B0
20222.6B2.7B2.7B2.7B
20212.6B2.6B2.6B2.6B
20203.3B3.0B2.8B2.7B
20193.4B3.4B3.4B3.3B
20183.6B3.5B3.5B3.5B
20173.6B3.6B3.6B3.6B
20163.2B3.4B3.5B3.6B
20152.6B2.7B2.8B3.0B
20142.2B2.3B2.4B2.6B
20132.0B2.0B2.1B2.1B
20121.7B1.8B1.9B1.9B
20111.5B1.6B1.6B1.7B
20101.2B1.3B1.4B1.4B
20091.1B1.1B1.2B1.2B
20080001.1B

Latest Insider Trading transactions for SRCL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 01, 2023
miller cindy j
acquired
-
-
2,232
chief executive officer
Nov 01, 2023
miller cindy j
sold (taxes)
-39,758
41.03
-969
chief executive officer
Jun 07, 2023
reuter joseph anthony
bought
308,619
44.0884
7,000
evp & chief people officer
May 26, 2023
chen thomas f
acquired
-
-
2,928
-
May 26, 2023
anderson brian p
acquired
-
-
2,928
-
May 26, 2023
hackney jesse joel jr
acquired
-
-
2,928
-
May 26, 2023
welch james l
acquired
-
-
2,928
-
May 01, 2023
rogers kurt
acquired
-
-
11,068
evp & general counsel
May 01, 2023
rogers kurt
sold (taxes)
-192,813
45.55
-4,233
evp & general counsel
Apr 14, 2023
weisman michael
acquired
-
-
333
evp corp ethics and compliance

1–10 of 50

Which funds bought or sold SRCL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
CITIGROUP INC
added
0.61
-67,993
2,099,270
-%
Dec 06, 2023
VisionPoint Advisory Group, LLC
new
-
5,589
5,589
-%
Nov 24, 2023
DEUTSCHE BANK AG\
reduced
-21.72
-342,393
1,047,560
-%
Nov 22, 2023
Graham Capital Management, L.P.
sold off
-100
-391,489
-
-%
Nov 21, 2023
COMERICA BANK
reduced
-83.21
1,942,580
1,943,580
0.01%
Nov 17, 2023
SkyView Investment Advisors, LLC
added
4.5
3,000
575,000
0.23%
Nov 16, 2023
Creative Planning
sold off
-100
-295,266
-
-%
Nov 15, 2023
CASTLEARK MANAGEMENT LLC
unchanged
-
-1,332
34,427
-%
Nov 15, 2023
MERCER GLOBAL ADVISORS INC /ADV
added
48.93
110,000
366,000
-%
Nov 15, 2023
Westside Investment Management, Inc.
unchanged
-
-173
4,471
-%

1–10 of 45

Latest Funds Activity

Are funds buying SRCL calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own SRCL
No. of Funds

Schedule 13G FIlings of Stericycle Inc

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
price t rowe associates inc /md/
4.9%
4,542,380
SC 13G/A
Feb 14, 2023
clarkston capital partners, llc
6.87%
6,332,330
SC 13G
Feb 14, 2023
alliancebernstein l.p.
7.6%
6,963,391
SC 13G/A
Feb 09, 2023
vanguard group inc
9.60%
8,845,201
SC 13G/A
Feb 08, 2023
black creek investment management inc.
5.59%
0
SC 13G
Feb 03, 2023
blackrock inc.
8.5%
7,803,191
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
12.0%
11,062,819
SC 13G/A
Feb 14, 2022
alliancebernstein l.p.
7.4%
6,841,439
SC 13G/A
Feb 10, 2022
vanguard group inc
9.10%
8,358,752
SC 13G/A
Feb 03, 2022
baillie gifford & co
4.72%
4,337,921
SC 13G/A

Recent SEC filings of Stericycle Inc

View All Filings
Date Filed Form Type Document
Nov 02, 2023
8-K
Current Report
Nov 02, 2023
4
Insider Trading
Nov 02, 2023
10-Q
Quarterly Report
Nov 01, 2023
4
Insider Trading

Peers (Alternatives to Stericycle Inc)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
94.7B
18.3B
3.48% -10.34%
27.11
5.17
8.46% 15.36%
56.4B
9.0B
5.22% 22.16%
40.86
6.28
10.68% 9.96%
45.8B
4.0B
2.47% 51.15%
34.57
11.46
11.51% 23.13%
27.6B
5.1B
22.05% 15.70%
53.03
5.38
-0.79% -26.63%
16.4B
10.0B
1.77% 17.96%
55.53
1.63
13.77% -44.30%
MID-CAP
9.2B
3.6B
3.65% -2.93%
16.56
2.55
15.88% 27.91%
8.8B
6.6B
11.39% 12.46%
18.66
1.32
-8.71% -30.48%
4.5B
2.7B
19.70% -3.59%
207.34
1.7
-0.52% 125.49%
4.4B
2.6B
8.13% 3.85%
8.11
1.7
11.12% 695.09%
2.9B
8.0B
9.25% -4.09%
12.04
0.36
6.99% 9.91%
SMALL-CAP
1.3B
1.5B
9.06% 23.93%
-51.78
0.86
80.96% -370.26%
339.9M
1.8B
6.92% -12.65%
34.96
0.19
17.94% 6.32%
127.6M
281.1M
12.08% -
11.35
0.45
-1.85% -2.83%
85.1M
998.5K
-11.24% 16.11%
-4.77
85.27
370.99% -10.42%
8.2M
84.5M
4.46% -23.55%
-4.35
0.1
9.61% -3025.62%

Stericycle Inc News

Latest updates
Defense World06 Dec 202311:03 am2 days ago
Marketscreener.com05 Dec 202311:01 am3 days ago
Yahoo Finance01 Dec 202305:37 pm6 days ago
Simply Wall St01 Dec 202310:50 am7 days ago
Insider Monkey28 Nov 202308:00 am10 days ago
Nasdaq15 Nov 202308:00 am23 days ago
Simply Wall St13 Nov 202308:00 am25 days ago
Yahoo Finance09 Nov 202308:00 am29 days ago
Yahoo Finance03 Nov 202307:00 am35 days ago
waste36001 Nov 202307:00 am37 days ago
North Carolina Health News27 Oct 202307:00 am42 days ago
Yahoo Finance24 Oct 202307:00 am45 days ago
Yahoo Finance18 Oct 202307:00 am51 days ago
Marketscreener.com10 Oct 202307:00 am59 days ago

Financials for Stericycle Inc

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue-2.4%654670684670690680664657649673668656636598785800833846830853855
Gross Profit-2.2%246251261255266261245247240269261270267230287280295303297329336
  S&GA Expenses-1.6%217221216211216222239251279214202219219201259246247277286315267
EBITDA Margin-100.0%-0.09*0.11*0.10*0.08*0.04*0.05*0.06*0.09*0.09*0.05*0.02*-0.08*-0.07*-0.08*------
Interest Expenses459.6%29.005.0033.008.0032.004.0028.002.0032.003.0020.006.0024.0010.0036.0032.0021.0027.0022.0032.0020.00
Income Taxes-17.2%5.006.009.006.005.008.003.008.00-3.009.0014.0023.007.009.00-38.40-8.80-8.60-3.004.00-56.9011.00
Earnings Before Taxes115.8%7.00-43.7020.0038.0033.0019.00-11.20-8.80-68.9038.0040.0072.00-74.405.00-58.30-228-67.60-33.20-34.00-37634.00
EBT Margin-100.0%-0.02*0.04*0.03*0.01*-0.03*-0.02*0.00*0.03*0.03*0.02*-0.02*-0.13*-0.12*-0.12*------
Net Income100.0%--49.5011.0032.0028.0011.00-14.10-16.40-65.9029.0026.0049.00-80.90-4.10-19.90-219-59.20-30.50-37.80-31824.00
Net Income Margin-100.0%-0.01*0.03*0.02*0.00*-0.03*-0.03*-0.01*0.01*0.01*0.00*-0.02*-0.12*-0.10*-0.10*------
Free Cashflow-100.0%-78.0013.0013126.00-12.10-76.3070.0026.0052.0038.0014013890.0043.00------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets0.6%5,2465,2135,3325,3345,3415,4085,4775,4735,4705,5175,5315,5825,6335,6856,3536,4376,6766,8706,8516,4566,903
  Current Assets11.4%5875275645595985976145765705485375535665931,203707751819802747803
    Cash Equivalents-3.3%30.0031.0060.0056.0044.0046.0060.0056.0038.0062.0050.0053.0059.0042.0036.0035.0031.0035.0048.0034.0052.00
  Net PPE1.5%703693713716712720713711704713702701696706728799786786760744755
  Goodwill-0.5%2,7392,7522,7882,7852,74924.002,8092,8162,7992,8142,8112,8192,8022,7862,7822,9823,1783,1953,1983,2223,614
Liabilities1.4%2,7702,7302,8862,9103,0153,0543,0963,0703,0473,0243,0833,1483,2953,3894,0734,1024,1994,3084,2803,8583,970
  Current Liabilities5.1%650619581622587619670732687677674697687660819757796784786733749
  Long Term Debt0.3%1,2971,2941,4871,4841,6521,6761,6781,5901,6211,6051,6511,6891,8791,9992,5192,5592,6172,6972,7022,6642,721
Shareholder's Equity-0.2%2,4762,4822,4462,4202,3222,3542,3812,4032,4222,4942,4492,4342,3392,2962,2802,3352,4772,5622,5712,5972,933
  Retained Earnings0.1%1,3751,3731,4221,4111,3791,3511,3411,3551,3721,4381,4091,3831,3341,4151,4201,4421,6621,7211,7511,7892,108
  Additional Paid-In Capital0.9%1,3121,3001,2891,2851,2811,2711,2631,2621,2541,2451,2361,2341,2281,2221,2131,2061,1971,1931,1711,1631,156
Accumulated Depreciation0.5%665662677658664681678659669662642630662642629668754738710678691
Shares Outstanding0%93.0093.0092.0092.0092.0092.0092.0092.0092.0092.0092.0092.0092.0091.0091.0091.0091.0091.0091.0091.0087.00
Minority Interest16.7%1.001.001.004.003.004.004.004.004.004.004.004.005.005.004.004.004.004.004.0010.0011.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations-63.6%38,400105,40049,500157,10061,50020,400-38,800100,90052,40087,20062,600165,000157,900125,20082,10046,800130,20034,80036,20075,800-141,100
  Share Based Compensation-4.6%10,40010,9006,9005,0007,5007,8004,8008,3006,6007,1005,1005,2007,4007,8005,1003,4003,7005,7004,3004,6006,700
Cashflow From Investing-168.8%-41,90060,900-34,50018,900-35,900-30,800-36,800-17,100-14,600-33,900-24,50053,200-24,100392,400-40,10037,300-48,200-40,800-52,300-38,100-26,000
Cashflow From Financing101.4%2,700-196,300-11,600-167,700-22,300-40079,400-64,700-60,600-42,500-40,100-224,200-117,300-511,400-39,600-81,600-83,300-8,00031,300-57,100174,600

SRCL Income Statement

2023-09-30
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Revenues$ 653.5$ 690.3$ 2,007.3$ 2,034.4
Cost of revenues407.8424.11,249.51,263.3
Gross profit245.7266.2757.8771.1
Selling, general and administrative expenses217.3215.6654.2676.5
Divestiture losses, net4.20.063.40.0
Income from operations24.250.640.294.6
Interest expense, net(17.4)(19.8)(56.9)(54.6)
Other income (expense), net0.12.3(0.3)0.8
Income (loss) before income taxes6.933.1(17.0)40.8
Income tax expense(4.8)(5.1)(19.1)(16.4)
Net income (loss)2.128.0(36.1)24.4
Net income attributable to noncontrolling interests(0.1)0.0(0.2)(0.2)
Net income (loss) attributable to Stericycle, Inc. common shareholders$ 2.0$ 28.0$ (36.3)$ 24.2
Income (loss) per common share attributable to Stericycle, Inc. common shareholders:    
Basic (in dollars per share)$ 0.02$ 0.30$ (0.39)$ 0.26
Diluted (in dollars per share)$ 0.02$ 0.30$ (0.39)$ 0.26
Weighted average number of common shares outstanding:    
Basic (in shares)92.592.292.492.1
Diluted (in shares)92.992.492.492.4

SRCL Balance Sheet

2023-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current Assets:  
Cash and cash equivalents$ 29.7$ 56.0
Accounts receivable, less allowance for doubtful accounts of $47.1 in 2023 and $53.3 in 2022465.6414.5
Prepaid expenses39.933.2
Other current assets52.055.0
Total Current Assets587.2558.7
Property, plant and equipment, less accumulated depreciation of $665.3 in 2023 and $657.7 in 2022702.8715.7
Operating lease right-of-use assets442.7398.9
Goodwill2,738.52,784.9
Intangible assets, less accumulated amortization of $889.2 in 2023 and $823.3 in 2022708.0811.1
Other assets66.964.8
Total Assets5,246.15,334.1
Current Liabilities:  
Current portion of long-term debt15.822.3
Bank overdrafts0.02.9
Accounts payable202.5213.5
Accrued liabilities219.6244.1
Operating lease liabilities102.191.2
Deferred revenues65.17.9
Other current liabilities45.340.0
Total Current Liabilities650.4621.9
Long-term debt, net1,297.01,484.0
Long-term operating lease liabilities360.5329.0
Deferred income taxes426.1427.0
Long-term income taxes payable9.411.8
Other liabilities26.435.9
Total Liabilities2,769.82,909.6
Commitments and contingencies (Note 8 - Commitments and Contingencies)
EQUITY  
Common stock (par value $0.01 per share, 120.0 shares authorized, 92.5 and 92.2 issued and outstanding in 2023 and 2022, respectively)0.90.9
Additional paid-in capital1,312.01,285.4
Retained earnings1,374.51,410.8
Accumulated other comprehensive loss(211.8)(276.9)
Total Stericycle, Inc.’s Equity2,475.62,420.2
Noncontrolling interests0.74.3
Total Equity2,476.32,424.5
Total Liabilities and Equity$ 5,246.1$ 5,334.1
SRCL
Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, controlled substance waste disposal, healthcare hazardous waste, and COVID 19 waste disposal; specialty services, such as MedDrop medication collection kiosks, safe community solutions, sharps mailback solutions, and maritime waste services; medical supply store services; pharmaceutical waste services; hazardous waste disposal; compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names. It also provides secure information destruction services, including document and hard drive destruction services under the Shred-it brand. The company serves healthcare businesses, including hospitals, health systems, physician and dental clinics, surgery centers, veterinary clinics, nursing and long-term care facilities, dialysis centers, pharmacy, lab, research centers, and home health organizations etc.; retailers and manufacturers; and airports and seaports, education institutions, funeral homes and crematories, government and military, banks and professional services, and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.
 CEO
 WEBSITEwww.stericycle.com
 EMPLOYEES14550

Stericycle Inc Frequently Asked Questions


What is the ticker symbol for Stericycle Inc? What does SRCL stand for in stocks?

SRCL is the stock ticker symbol of Stericycle Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Stericycle Inc (SRCL)?

As of Thu Dec 07 2023, market cap of Stericycle Inc is 4.54 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SRCL stock?

You can check SRCL's fair value in chart. The fair value of Stericycle Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Stericycle Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SRCL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Stericycle Inc a good stock to buy?

The fair value guage provides a quick view whether SRCL is over valued or under valued. Whether Stericycle Inc is cheap or expensive depends on the assumptions which impact Stericycle Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SRCL.

What is Stericycle Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, SRCL's PE ratio (Price to Earnings) is 207.34 and Price to Sales (PS) ratio is 1.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SRCL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Stericycle Inc's stock?

In the past 10 years, Stericycle Inc has provided -0.082 (multiply by 100 for percentage) rate of return.